| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 07/23/2002 | US6423715 Thiazolobenzoheterocycles, their preparation and medicaments containing them |
| 07/23/2002 | US6423712 2,4-Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
| 07/23/2002 | US6423710 Cyclic AMP-specific phosphodiesterase inhibitors |
| 07/23/2002 | US6423709 Methods of using novel compounds as neuro-protective agents |
| 07/23/2002 | US6423708 Aralkyl and aralkylidene heterocyclic lactams and imides |
| 07/23/2002 | US6423342 Fast dispersing composition with selegiline |
| 07/23/2002 | CA2365997A1 Novel polypeptide |
| 07/23/2002 | CA2204911C Glial derived neurotrophic factor as a neuroprotective agent |
| 07/23/2002 | CA2087723C Treatment with flurbiprofen of pain and inflammation in mammals |
| 07/23/2002 | CA2072642C Fusion proteins consisting of a ligand binding protein and a stable plasma protein |
| 07/23/2002 | CA2041594C Pyrido[2,3-f][1,4]thiazepines and pyrido[3,2-b][1,5]benzothiazepines |
| 07/22/2002 | CA2368485A1 Combination treatment for depression |
| 07/18/2002 | WO2002056027A2 Regulation of neutral development by daedalos |
| 07/18/2002 | WO2002055720A2 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 07/18/2002 | WO2002055693A2 Method for inhibiting the expression of a target gene |
| 07/18/2002 | WO2002055690A1 Novel g protein-coupled receptor protein and dna thereof |
| 07/18/2002 | WO2002055681A2 Regulation of human tau-tubulin kinase |
| 07/18/2002 | WO2002055552A2 Soluble cyclic analogues of beta amyloid peptide |
| 07/18/2002 | WO2002055541A2 Peptides having inhibiting activity on the production of nitric oxide |
| 07/18/2002 | WO2002055524A1 THIENO(3,2-d)PYRIMIDINES AND FURANO(3,2-d)PYRIMIDINES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 07/18/2002 | WO2002055521A1 Purine derivatives as purinergic receptor antagonists |
| 07/18/2002 | WO2002055518A1 1-(2-methoxybenzyl)-3-benzhydrylpiperazines as tachykinin antagonists |
| 07/18/2002 | WO2002055514A2 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators |
| 07/18/2002 | WO2002055510A1 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 07/18/2002 | WO2002055502A1 Pyridine derivatives useful as cyclooxygenase inhibitor |
| 07/18/2002 | WO2002055501A2 N-pyridyl carboxamide derivatives and pharmaceutical compositions containing them |
| 07/18/2002 | WO2002055498A1 Pharmaceutically active piperidine derivatives |
| 07/18/2002 | WO2002055492A2 An improved process for preparing pure ondansetron hydrochloride dihydrate |
| 07/18/2002 | WO2002055485A1 Prodrugs of excitatory amino acids |
| 07/18/2002 | WO2002055481A1 Prodrugs of excitatory amino acids |
| 07/18/2002 | WO2002055479A2 Esters of alkylcarboxy amino acids as prodrugs of modulators of the kainate receptor |
| 07/18/2002 | WO2002055108A1 Targeted modification of intracellular compounds |
| 07/18/2002 | WO2002055099A2 Modulation of pericyte proliferation using bpi protein products or bpi inhibitors |
| 07/18/2002 | WO2002055093A2 Activated charcoal based composition and method for reducing hangover symptoms associated with the consumption of alcohol containing beverages |
| 07/18/2002 | WO2002055084A1 PYRROLO[2,3-d]PYRIMIDINE AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 07/18/2002 | WO2002055083A1 TRIAZOLO[4,5-d] PYRIMIDINE DERIVATIVES AND THEIR USE AS PURINERGIC RECEPTOR ANTAGONISTS |
| 07/18/2002 | WO2002055082A1 Pyrazolo[3,4-d]pyrimidine derivatives and their use as purinergic receptor antagonists |
| 07/18/2002 | WO2002055078A2 Use of chromanes for treating parkinson's disease |
| 07/18/2002 | WO2002055077A1 Use of imidazolyl cyclic acetal derivatives in the manufacture of a medicament for the treatment of diseases mediated by the alk5 receptors |
| 07/18/2002 | WO2002055070A1 Dihydrofuran cyclic tanshintones used in treating hyperammonemia and hepatic encephalopathy |
| 07/18/2002 | WO2002055067A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 07/18/2002 | WO2002055066A1 Fumaric acid derivatives as nf-kappa-b inhibitors |
| 07/18/2002 | WO2002055063A2 Fumaric acid amides |
| 07/18/2002 | WO2002055016A2 INHIBITION OF NF-λB BY TRITERPENE COMPOSITIONS |
| 07/18/2002 | WO2002055014A2 Therapeutic chroman compounds |
| 07/18/2002 | WO2002055013A2 Therapeutic chromone compounds |
| 07/18/2002 | WO2002055012A2 Therapeutic heterocyclic compounds |
| 07/18/2002 | WO2002055010A2 Pharmaceutical compositions comprising modified cns-derived peptides for promoting nerve regeneration and prevention of nerve degeneration |
| 07/18/2002 | WO2002042250B1 DERIVATIVES OF 4-HYDROXYBUTANOIC ACID AND OF ITS HIGHER HOMOLOGUE AS LIGANDS OF η-HYDROXYBUTYRATE (GHB) RECEPTORS, PHARMACEUTICAL COMPOSITIONS CONTAINING SAME AND PHARMACEUTICAL USES |
| 07/18/2002 | WO2002034699A3 Mammalian metabolites of a tachykinin receptor antagonist |
| 07/18/2002 | WO2002034202A3 Multi-component antioxidant compounds, pharmaceutical compositions containing same and their use for reducing or preventing oxidative stress |
| 07/18/2002 | WO2002030377A3 Product for cleaning teeth and/or the mouth |
| 07/18/2002 | WO2002029088A3 Highly expressible genes |
| 07/18/2002 | WO2002024661A3 New n, n'-disubstituted benzimidazolone derivatives with affinity at the serotonin and dopamine receptors |
| 07/18/2002 | WO2002022558A3 2-amino-2-alkyl-3 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 07/18/2002 | WO2002020481A3 Substituted 4-phenyl-1-(1-phenyl-cyclohexyl)-1,2,3,6-tetrahydropyridine |
| 07/18/2002 | WO2002016358A3 Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands) |
| 07/18/2002 | WO2002016355A3 Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic) acetylcholine receptor ligands |
| 07/18/2002 | WO2002015937A3 Pharmaceutical composition for the systematic administration of pharmacologically active ingredients containing polyol fatty acid esters |
| 07/18/2002 | WO2002013758A3 System for regulating in vivo the expression of a transgene by conditional inhibition |
| 07/18/2002 | WO2002012224A3 Bicyclic compounds as h3 receptor ligands |
| 07/18/2002 | WO2002009713A3 Selective pde 2 inhibitors, used as medicaments for improving cognition |
| 07/18/2002 | WO2002007766A3 Use of d5-dopamine receptor agonists in the manufacture of a medicament for the treatment of dyskinesia |
| 07/18/2002 | WO2002006316A3 Alpha-msh related compounds and methods of use |
| 07/18/2002 | WO2002006242A3 5-substituted 2-aryl-4-pyrimidinones |
| 07/18/2002 | WO2002004409A3 Tetrahydrobenzothiazole analogues as neuroprotective agents |
| 07/18/2002 | WO2002002633A3 Transporters and ion channels |
| 07/18/2002 | WO2002002556A3 AZA-BRIDGED-BICYCLIC AMINO ACID DERIVATIVES AS α4 INTEGRIN ANTAGONISTS |
| 07/18/2002 | WO2002000623A3 Aryl fused substituted 4-oxy-pyridines |
| 07/18/2002 | WO2001094391A3 Intracellular signaling proteins |
| 07/18/2002 | WO2001090103A3 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives and their use as protein kinase modulators |
| 07/18/2002 | WO2001088134A3 Novel human lipocalin homologs and polynucleotides encoding the same |
| 07/18/2002 | WO2001088132A3 Rabies virus-specific neutralizing human monoclonal antibodies and nucleic acids and related methods |
| 07/18/2002 | WO2001087980A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 07/18/2002 | WO2001085790A3 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 07/18/2002 | WO2001083749A3 Gene and sequence variation associated with sensing carbohydrate compounds and other sweeteners |
| 07/18/2002 | WO2001081590A3 Protein phosphatases |
| 07/18/2002 | WO2001079282A3 Molecules associated with human reproduction |
| 07/18/2002 | WO2001078789A3 Poliovirus replicons encoding therapeutic agents and uses thereof |
| 07/18/2002 | WO2001074340A3 Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug |
| 07/18/2002 | WO2001072728A3 Novel piperazine derivatives |
| 07/18/2002 | WO2001068065A9 Compositions comprising blockers of l-dopa renal cell transfer for the treatment of parkinson's disease |
| 07/18/2002 | WO2001066747A3 Proteins named fctrx and nucleic acids encoding same |
| 07/18/2002 | WO2001064201A3 Restricting reinstatement of drug use |
| 07/18/2002 | WO2001060370A1 Remedies for endothelin-induced diseases |
| 07/18/2002 | WO2001051520A9 Nogo receptor-mediated blockade of axonal growth |
| 07/18/2002 | WO2001044514A3 Methods and compositions for identifying morphogenic protein analogs using morphogenic protein responsive inhibitory elements |
| 07/18/2002 | WO2001041756A3 Method and composition for treatment of ischemic neuronal reperfusion injury |
| 07/18/2002 | WO2001039766A3 Screening invertebrate pheromones for therapeutic activity |
| 07/18/2002 | WO2001008682A3 Use of flupirtine for alleviating pain caused by degenerative joint diseases in dogs and cats |
| 07/18/2002 | WO2001005834A9 Human tumor necrosis factor receptors tr13 and tr14 |
| 07/18/2002 | WO2000078972A9 Regulation with binding cassette transporter protein abc1 |
| 07/18/2002 | US20020095024 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 07/18/2002 | US20020095023 Membrane protein for use in the treatment of allergies, parkinson's, alzheimer's and apoptitic defects |
| 07/18/2002 | US20020094999 Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias |
| 07/18/2002 | US20020094998 Methods and compositions for treatment of ocular neovascularization and neural injury |
| 07/18/2002 | US20020094987 Amide or thioamide substituted benzimidazole or quinoxaline derivatives; therapeutic utility via inhibition of tumor necrosis factor or phosphodiesterase |
| 07/18/2002 | US20020094986 Combination treatment for depression, anxiety and psychosis |
| 07/18/2002 | US20020094979 Use of 5HT-6 antagonists |
| 07/18/2002 | US20020094975 Effective to block sensory and motor functions of a nerve(s) at the site of administration; treating all categories of pain - acute or chronic, local or general; interfering with the nerve(s) propagating such pain |